These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26856838)

  • 1. Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.
    Webb BJ; Dascomb K; Stenehjem E; Vikram HR; Agrwal N; Sakata K; Williams K; Bockorny B; Bagavathy K; Mirza S; Metersky M; Dean NC
    Antimicrob Agents Chemother; 2016 May; 60(5):2652-63. PubMed ID: 26856838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients.
    Park SC; Kim EY; Kang YA; Park MS; Kim YS; Kim SK; Chang J; Jung JY
    Int J Tuberc Lung Dis; 2013 May; 17(5):704-9. PubMed ID: 23575340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a clinical risk score for predicting drug-resistant bacterial pneumonia in older Chinese patients.
    Ma HM; Ip M; Woo J; Hui DS
    Respirology; 2014 May; 19(4):549-55. PubMed ID: 24661357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
    Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
    Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia.
    Self WH; Wunderink RG; Williams DJ; Barrett TW; Baughman AH; Grijalva CG
    Acad Emerg Med; 2015 Jun; 22(6):730-40. PubMed ID: 25996620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictors of drug-resistant pathogens in community-onset pneumonia: Are factors considered in health-care-associated pneumonia useful in the emergency department?].
    Torres Bonafonte OH; Gil Olivas E; Pérez Macho E; Pacho Pacho C; Mateo Roca M; Casademont Pou J; Ruiz Hidalgo D
    Emergencias; 2017 Oct; 29(5):306-312. PubMed ID: 29077289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia.
    Park SC; Kang YA; Park BH; Kim EY; Park MS; Kim YS; Kim SK; Chang J; Jung JY
    Respir Med; 2012 Sep; 106(9):1311-9. PubMed ID: 22560114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia?
    Schreiber MP; Chan CM; Shorr AF
    Chest; 2010 Jun; 137(6):1283-8. PubMed ID: 20154075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.
    Webb BJ; Sorensen J; Mecham I; Buckel W; Ooi L; Jephson A; Dean NC
    Chest; 2019 Nov; 156(5):843-851. PubMed ID: 31077649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Bacterial Aetiology, Antibiotic Resistance and Treatment Outcomes: A Study From North India.
    Kumar S; Jan RA; Fomda BA; Rasool R; Koul P; Shah S; Khan UH; Qadri SM; Masoodi SR; Mantoo S; Muzamil M
    Lung; 2018 Aug; 196(4):469-479. PubMed ID: 29691645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.
    Schweitzer VA; van Werkhoven CH; van Heijl I; Smits RF; Boel CHE; Bonten MJM; Postma DF; Oosterheert JJ
    Neth J Med; 2018 Nov; 76(9):389-396. PubMed ID: 30465653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    Arch Intern Med; 2008 Nov; 168(20):2205-10. PubMed ID: 19001196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Validation of Drug Resistance in Pneumonia (DRIP) Score in Predicting Infections due to Drug-Resistant Pathogens in Community-acquired Pneumonia at Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
    Fadrian F; Chen K; Kumalawati J; Rumende CM; Shatri H; Nelwan EJ
    Acta Med Indones; 2021 Oct; 53(4):416-422. PubMed ID: 35027488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a Community-Acquired Pneumonia Score To Improve Empiric Antibiotic Selection at an Academic Medical Center.
    Oliver MB; Fong K; Certain L; Spivak ES; Timbrook TT
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department.
    Shorr AF; Zilberberg MD; Reichley R; Kan J; Hoban A; Hoffman J; Micek ST; Kollef MH
    Clin Infect Dis; 2012 Jan; 54(2):193-8. PubMed ID: 22109951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation and Validation of a Clinical Prediction Score to Identify the Isolation of Pseudomonas in Pneumonia.
    Maskov Y; Sanders JM; Tilahun B; Hennessy SA; Reisch J; Johns M
    Microbiol Spectr; 2022 Jun; 10(3):e0042422. PubMed ID: 35604182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.